These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16859599)

  • 1. Long-term outcome of giant cell arteritis.
    Pipitone N; Boiardi L; Bajocchi G; Salvarani C
    Clin Exp Rheumatol; 2006; 24(2 Suppl 41):S65-70. PubMed ID: 16859599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Glucocorticoid-induced adverse events in patients with giant cell arteritis or polymyalgia rheumatica].
    Fardet L
    Rev Med Interne; 2013 Jul; 34(7):438-43. PubMed ID: 23743479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of giant cell arteritis].
    Samson M; Greigert H; Bonnotte B
    Rev Prat; 2023 Apr; 73(4):395-399. PubMed ID: 37289152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Polymyalgia rheumatica and giant-cell arteritis].
    Glazunov AV; Zhiliaev EV; Toldieva FA; Dzhanashiia PKh
    Klin Med (Mosk); 2005; 83(11):39-45. PubMed ID: 16404938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial.
    Mazlumzadeh M; Hunder GG; Easley KA; Calamia KT; Matteson EL; Griffing WL; Younge BR; Weyand CM; Goronzy JJ
    Arthritis Rheum; 2006 Oct; 54(10):3310-8. PubMed ID: 17009270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are steroids alone sufficient for the treatment of giant cell arteritis?
    Pipitone N; Boiardi L; Salvarani C
    Best Pract Res Clin Rheumatol; 2005 Apr; 19(2):277-92. PubMed ID: 15857796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The bane of giant cell arteritis from an ophthalmological viewpoint].
    Meli B; Landau K; Gloor BP
    Schweiz Med Wochenschr; 1996 Oct; 126(43):1821-8. PubMed ID: 9005521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymyalgia rheumatica and giant-cell arteritis.
    Salvarani C; Cantini F; Hunder GG
    Lancet; 2008 Jul; 372(9634):234-45. PubMed ID: 18640460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discontinuation of therapies in polymyalgia rheumatica and giant cell arteritis.
    Muratore F; Pipitone N; Hunder GG; Salvarani C
    Clin Exp Rheumatol; 2013; 31(4 Suppl 78):S86-92. PubMed ID: 24129145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors and long-term evolution in a cohort of 133 patients with giant cell arteritis.
    Hachulla E; Boivin V; Pasturel-Michon U; Fauchais AL; Bouroz-Joly J; Perez-Cousin M; Hatron PY; Devulder B
    Clin Exp Rheumatol; 2001; 19(2):171-6. PubMed ID: 11326479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving therapeutic options for patients with giant cell arteritis.
    Pipitone N; Salvarani C
    Curr Opin Rheumatol; 2008 Jan; 20(1):17-22. PubMed ID: 18281852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Giant cell arteritis presenting with bilateral loss of vision and jaw pain: reminder of a potentially devastating condition.
    Sheldon CA; White VA; Holland SP
    J Can Dent Assoc; 2011; 77():b55. PubMed ID: 21627866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bilateral amaurosis in 11 patients with giant cell arteritis confirmed by arterial biopsy].
    Wenkel H
    Klin Monbl Augenheilkd; 2001 Oct; 218(10):658-61. PubMed ID: 11706381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory disease in older adults. Cranial arteritis.
    Spiera R; Spiera H
    Geriatrics; 2004 Dec; 59(12):25-9; quiz 30. PubMed ID: 15667019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Slowly progressive vision loss in giant cell arteritis.
    Galor A; Lee MS
    Arch Ophthalmol; 2006 Mar; 124(3):416-8. PubMed ID: 16534064
    [No Abstract]   [Full Text] [Related]  

  • 16. Polymyalgia rheumatica and giant cell arteritis.
    Unwin B; Williams CM; Gilliland W
    Am Fam Physician; 2006 Nov; 74(9):1547-54. PubMed ID: 17111894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The erythrocyte sedimentation rate is associated with the development of visual complications in biopsy-proven giant cell arteritis.
    Lopez-Diaz MJ; Llorca J; Gonzalez-Juanatey C; Peña-Sagredo JL; Martin J; Gonzalez-Gay MA
    Semin Arthritis Rheum; 2008 Oct; 38(2):116-23. PubMed ID: 18221984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visual loss due to central serous chorioretinopathy during corticosteroid treatment for giant cell arteritis.
    Bevis T; Ratnakaram R; Smith MF; Bhatti MT
    Clin Exp Ophthalmol; 2005 Aug; 33(4):437-9. PubMed ID: 16033370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does glucocorticosteroid-resistant large-vessel vasculitis (giant cell arteritis and Takayasu arteritis) exist and how can remission be achieved? A critical review of the literature.
    Kötter I; Henes JC; Wagner AD; Loock J; Gross WL
    Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S114-29. PubMed ID: 22640655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.
    Unizony S; Arias-Urdaneta L; Miloslavsky E; Arvikar S; Khosroshahi A; Keroack B; Stone JR; Stone JH
    Arthritis Care Res (Hoboken); 2012 Nov; 64(11):1720-9. PubMed ID: 22674883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.